MEANS AND METHODS OF MULTIDIMENSIONAL MODELING IN VIVO SPATIAL IMAGE OF AN MRI CONTRAST AGENT

• US 20140142914A1
• Filed: 07/11/2013
• Published: 05/22/2014
• Est. Priority Date: 11/22/2012
• Status: Abandoned Application

• Current Assignee: Aspect Imaging Ltd.
• Original Assignee: Aspect Imaging Ltd.
• Inventors: RAPOPORT, Uri
• Application Number:
  US13/939,564
• Publication Number:
  US 20140142914A1
• Time in Patent Office: Days
• US Class Current: 703/11
• CPC Class Codes: A61B 5/0071 by measuring fluorescence emission
• CPC Class Codes: A61B 5/055 involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
• CPC Class Codes: A61B 6/481 involving the use of contrast agents

Abstract

A method of multidimensional modeling a magnetic resonance device (MRD) contrast agent introduced within the body of a patient. The method includes: introducing into the patient body or an organ an effective measure of at least one MRD contrast agent; imaging the MRD contrast agent located at least a portion of a body and providing data defining a multidimensional image; loading or otherwise streaming the MRD image to a multidimensional printer; and multidimensionally modeling the MRD contrast agent.

Claims

1. A method of multidimensional modeling an MRD contrast agent (MCA) introduced within the body of a patient, the method comprises steps as follows:

a. introducing into patient body or an organ thereof an effective measure of at least one MCA;

b. by means of an MRD, imaging said MCA located at least a portion of a body and providing data defining a multidimensional image of the same;

c. loading or otherwise streaming said MRD image to a multidimensional printer; and

d. multidimensionally modeling said MCA.

2. The method of claim 1, wherein said MRD is selected from a group consisting of CAT scanner, ultrasound imager, infrared imager, X-radiography detecting device, Raman spectroscope, single photon emission computed tomography detector or microwave imager, NMR, MRI, ESR, CT and a combination thereof.

3. The method of claim 1, wherein said multidimensional modeling is selected from a group consisting of 2D modeling and 3D modeling and wherein said multidimensional printer is a 2D and 3D printer, respectively.

4. A multidimensional modeling system comprising:

a. means for introducing into patient'"'"'s body or organ thereof an effective measure of at least one MCA;

b. an MRD for imaging said MCA within at least a portion of said body r organ thereof;

c. a readable computer data defining a multidimensional image of the same;

d. at least one multidimensional printer in communication with said data for multidimensionally modeling said MCA.

5. The multidimensional modeling system of claim 4, wherein said MRD is selected from a group consisting of CAT scanner, ultrasound imager, infrared imager, X-radiography detecting device, Raman spectroscope, single photon emission computed tomography detector or microwave imager, NMR, MRI, ESR, CT and a combination thereof.

6. The multidimensional modeling system of claim 4, wherein said multidimensional model is selected from a group consisting of 2D model and 3D model and wherein said multidimensional printer is a 2D and 3D printer, respectively.

11. The multidimensional modeling system of claim 4, wherein said MRD is selected from a group consisting of MRI, ESR, CT and a combination thereof.

12. The multidimensional modeling system of claim 4, wherein said multidimensional model is selected from a group consisting of 2D model and 3D model and wherein said multidimensional printer is a 2D and 3D printer, respectively.

7. A method of a complex multidimensional modeling an MRD contrast agent (MCA) introduced within the body of a patient, the method comprises steps as follows:

a. introducing into patient'"'"'s body or an organ thereof an effective measure of at least one MCA;

b. by means of at least one first MRD, imaging at least one first MCA located at least a portion of said body or organ thereof and providing data defining a multidimensional image of the same;

c. by means at least one second MRD, imaging at least one second MCA located at least a portion of said body of organ thereof and providing data defining a multidimensional image of the same;

d. loading or otherwise streaming said least one first MRD image and said least one second MRD image to a multidimensional printer; and

e. multidimensionally modeling said MCA such that a complex multidimensional model of said MCA is provided.

8. The method of claim 7, wherein said least one first MRD and said least one second MRD are selected from a group consisting of CAT scanner, ultrasound imager, infrared imager, X-radiography detecting device, Raman spectroscope, single photon emission computed tomography detector or microwave imager, NMR, MRI, ESR, CT and a combination thereof.

9. The method of claim 7, wherein said multidimensional modeling is selected from a group consisting of 2D modeling and 3D modeling and wherein said multidimensional printer is a 2D and 3D printer, respectively.

10. A complex multidimensional modeling system comprising:

a. means for introducing into patient'"'"'s body or organ thereof an effective measure of at least one first MCA and at least one second MCA;

b. at least one first MRD for imaging at least one first MCA within at least a portion of said body or organ thereof and at least one second MRD for imaging at least one second MCA within at least a portion of said body or organ thereof;

c. a readable computer data defining at least one first multidimensional image and at least one second multidimensional image of the same;

d. a computer processing unit for superimposing or otherwise imbedding said at least one first multidimensional image with at least one second multidimensional image;

e. at least one multidimensional printer in communication with said data for multidimensionally modeling said superimposed or otherwise embedded at least one first MCA and at least one second image.

13. A method of multidimensional modeling contrast agent and fluorophores heterogeneous sources introduced within the body of a patient, the method comprises steps as follows:

a. introducing into patient'"'"'s body or an organ thereof an effective measure of at least one first MCA and at least one second MCA;

b. by means of at least one MRD, scanning said at least one first MCA located at least a portion of said body or organ thereof and providing data defining a multidimensional image of the same;

c. by means at least one optical detector, detecting said at least one second MCA located at least a portion of said body of organ thereof and providing data defining spatial emission of the same;

d. loading or otherwise streaming said least one first MRD image and said least one second MRD image to a multidimensional printer; and

e. multidimensionally modeling said MCA such that a complex multidimensional model of said MCA is provided.

14. The method of claim 13, wherein said least one first MRD and said least one second MRD are selected from a group consisting of CAT scanner, ultrasound imager, infrared imager, X-radiography detecting device, Raman spectroscope, single photon emission computed tomography detector or microwave imager, NMR, MRI, ESR, CT and a combination thereof.

15. The method of claim 13, wherein said multidimensional modeling is selected from a group consisting of 2D modeling and 3D modeling and wherein said multidimensional printer is a 2D and 3D printer, respectively.

16. The method of claim 13, wherein said least one second MRD is a fluorescence emission camera.

17. The method of claim 13, wherein said one second MCA is a NIR fluorophore.

18. A system for multidimensional modeling contrast agent-fluorophores heterogeneous-sources, the system comprising

a. means for introducing into patient'"'"'s body or an organ thereof an effective measure of at least one first MCA and least one second MCA;

b. at least one MRD, useful for (i) scanning said at least one first MCA located at least a portion of said body or organ thereof, and (ii) providing data defining a multidimensional image of the same;

c. at least one optical detector, useful for (i) detecting at least one second MCA located at least a portion of said body of organ thereof, and (ii) providing data defining spatial emission of the same;

d. a root of communication for loading or otherwise streaming said least one first MRD image and said least one second MRD image to at least one multidimensional printer; and

e. multidimensionally modeling said MCAs such that a complex multidimensional model of said MCAs is provided.

19. The system of claim 18, wherein said least one first MRD and said least one second MRD are selected from a group consisting of CAT scanner, ultrasound imager, infrared imager, X-radiography detecting device, Raman spectroscope, single photon emission computed tomography detector or microwave imager, NMR, MRI, ESR, CT and a combination thereof.

20. The system of claim 18, wherein said multidimensional model is selected from a group consisting of 2D model and 3D model and wherein said multidimensional printer is a 2D and 3D printer, respectively.

21. The system of claim 18, wherein said least one second MRD is a fluorescence emission camera.

22. The system of claim 18, wherein said one second MCA is a NIR fluorophore.